𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effects of clobazam upon critical flicker fusion thresholds: A review

✍ Scribed by Dr. A. C. Parrott

Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
531 KB
Volume
2
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effects of clobazam on critical flic
The effects of clobazam on critical flicker fusion threshold and symptomatology during the menstrual cycle
✍ Louise Dye; Ian Hindmarch πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 805 KB

The effects of clobazam on critical flicker fusion threshold (CFFT) and menstrual cycle-related symptomatology were examined in a double-blind placebo-controlled study of 11 normally cycling women. Clobazam 10 mg or placebo was administered in two doses, the evening before and the morning of testing

The Effects of Practice on Choice Reacti
The Effects of Practice on Choice Reaction Time and Critical Flicker Fusion Threshold
✍ CLARE PARKIN; JOHN S. KERR; IAN HINDMARCH πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

The use of psychometrics in psychopharmacology assumes that subjects are trained to `plateau' performance levels prior to experimental data being collected. Fourteen healthy, naive volunteers were tested on CFF and CRT over a 5-day period. On days 1 and 5 subjects carried out the tests six times, wi

Critical flicker fusion threshold: a pot
Critical flicker fusion threshold: a potentially useful measure for the early detection of Alzheimer's disease
✍ Stephen Curran; John Wattis πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 2 views

Critical Flicker Fusion Threshold (CFFT) is a psychophysical threshold and, in psychological terms, it is regarded as a measure of information processing capacity. CFFT has previously been shown to be a valid and reliable measure in young healthy volunteers and it also has a long history of use as a

Explaining ADAGIO: A critical review of
Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
✍ Peter Jenner; J. William Langston πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 201 KB

## Abstract The ADAGIO study demonstrated a symptomatic benefit for rasagiline in early Parkinson's disease (PD) and suggested a disease‐modifying effect. Evidence indicates that mitochondrial dysfunction plays a role in the pathogenesis of PD and that this may be the site of effect for rasagiline.